Liberia is one of 12 African countries which started administering their first anti-malaria vaccine. The government had announced that 88,780 vaccine vials are already available, with more doses expected in July 2024.
WHO’s Malaria Vaccine Implementation Program focuses on areas with high malaria prevalence, particularly among children.
Liberia:
Liberia Launches Anti-Malaria Vaccine for Children 5-18 Months Today
FrontPageAfrica, 24 April 2024
Liberia is taking a significant step forward in its fight against malaria with the official launch of an anti-malaria vaccine for children aged 5 to 18 months. The launch ceremony… Read more »
Africa:
Two New Malaria Vaccines Are Being Rolled Out Across Africa – How They Work and What They Promise
The Conversation Africa, 22 April 2024
Malaria incidents are on the rise. There were 249 million cases of this parasitic disease in 2022, five million more than in 2021. Africa suffers more than any other region from… Read more »
Africa:
Nearly 10 000 Children Vaccinated As Malaria Vaccine Rollout in Africa Expands
WHO-AFRO, 9 February 2024
Nearly 10 000 children in Burkina Faso and Cameroon have now received the RTS,S malaria vaccine since being introduced this year. A wider malaria vaccine rollout is underway this… Read more »
Liberia:
Liberia Receives 112,000 Doses of Malaria Vaccine
New Dawn, 26 January 2024
The Ministry of Health in collaboration with Gavi, the Vaccine Alliance, World Health Organization (WHO), and the United Nations Children’s Fund (UNICEF), has announced the arrival… Read more »
Africa:
Malaria Vaccine is Here – ‘The World Needs Good News – And This is a Good News Story’
WHO, 22 November 2023
Shipments of the world’s first WHO-recommended malaria vaccine, RTS,S, have begun with 331 200 doses landing last night in Yaoundé, Cameroon. The delivery is the first to a… Read more »
The World Health Organization (WHO) has recommended a new, inexpensive malaria vaccine to prevent malaria in children that can be produced on a massive scale, reports Read more »
A recently announced follow-on collaboration between the PATH Malaria Vaccine Initiative (MVI) and Invovio Pharmaceuticals will test whether a novel vaccine approach that combines … Read more »
The malaria burden is the highest on the African continent, which accounted for approximately 95% of global malaria cases and 96% of related deaths in 2021. With several African … Read more »
Trial participant being vaccinated in Kenya (file phto).
